|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
4694795 |
005 |
20030601210300.0 |
008 |
020726s1996 enka b 100 0 eng d |
003 |
ICU |
035 |
|
|
|a (OCoLC)50523294
|
040 |
|
|
|a ICU
|c ICU
|d OCoLC
|
090 |
|
|
|a R31
|b .R474 v.18 no.3
|
245 |
0 |
0 |
|a Oral cytotoxic treatment in haematological malignancies :
|b proceedings of a meeting held at Sunstar Park Hotel, Davos, Switzerland, 18th March 1995 /
|c editor: M.J. Keating.
|
260 |
|
|
|a Kent, Eng. :
|b Wells Medical,
|c 1996.
|
300 |
|
|
|a 93 p. :
|b ill. ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Research and clinical forums
|v v. 18, no. 3
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a Introduction / M.J. Keating -- Pharmacokinetics and metabolism of oral idarubicin / M. Strolin Benedetti -- Discussion -- Current and future strategies for advanced low-grade non-Hodgkin's lymphoma / A. Engert -- The use of oral idarubicin, chlorambucil and dexamethasone in low-grade non-Hodgkin's lymphoma / S.J. Proctor and P.R.A. Taylor -- Discussion -- Clinical experience with oral idarubicin in low-grade non-Hodgkin's lymphomas / D.C. Case Jr. -- Discussion -- Oral agents for the treatment of AML: clinical experience with oral idarubicin / J.L. Harousseau -- Discussion -- Results of a randomised comparison or oral etaposide, thioguanine and idarubicin (ETI) with thioguanine, cytarabine and daunorubicin (TAD) in elderly patients with acute myeloid leukaemia / T. Ruutu -- Discussion -- Which group of AML patients should be treated with oral idarubicin? / M.J. Keating -- Discussion -- The role of idarubicin in the treatment of multiple myeloma / S. Tura and M. Cavo -- Discussion -- Oral idarubicin with dexamethasone (Z-Dex) as initial therapy in multiple myeloma / I.M. Franklin, ... [et al.] -- Discussion -- Oral idarubicin with CCNU (lomustine) and dexamethasone in the treatment of refractory or relapsed multiple myeloma / D. Samson -- Discussion.
|
650 |
|
0 |
|a Blood
|x Diseases
|v Congresses.
|
650 |
|
0 |
|a Lymphomas
|x Treatment
|v Congresses.
|
650 |
|
0 |
|a Acute myelocytic leukemia
|x Treatment
|v Congresses.
|
650 |
|
0 |
|a Multiple myeloma
|x Treatment
|v Congresses.
|
650 |
|
7 |
|a Blood
|x Diseases.
|2 fast
|0 http://id.worldcat.org/fast/fst00834579
|
650 |
|
7 |
|a Lymphomas
|x Treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst01004329
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
700 |
1 |
|
|a Keating, Michael J.
|q (Michael Joseph),
|d 1943-
|0 http://id.loc.gov/authorities/names/n83157203
|1 http://viaf.org/viaf/72323726
|
901 |
|
|
|a Analytic
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i a29b03f6-fd91-505f-95b4-05fd0a419286
|s b3e96e40-121f-517b-ab86-12df6db19d9e
|
928 |
|
|
|t Library of Congress classification
|a R31.R474 v.18 no.3
|l ASR
|c ASR-SciASR
|i 4394686
|
927 |
|
|
|t Library of Congress classification
|a R31.R474 v.18 no.3
|l ASR
|c ASR-SciASR
|g Analytic
|e CRERAR
|b A54470003a
|i 7301401
|